James Lim, PhD, on Addressing Lingering Needs in Research Process Development and Clinical Manufacturing
The cofounder and chief scientific officer of Xcell Biosciences discussed the company’s efforts to introduce new technologies for improving cell therapy development and manufacturing.
James Lim, PhD, on the Impact of Manufacturing Conditions on CAR-T Efficacy
The cofounder and chief scientific officer of Xcell Biosciences discussed the company’s manufacturing-focused approach to overcoming the challenges of the solid tumor microenvironment.
James Lim, PhD, on Simulating the Solid Tumor Microenvironment in Cell Killing Assays
The cofounder and chief scientific officer of Xcell Biosciences discussed the company’s research with a newly developed assay method that was presented at AACR’s 2023 conference.
James Lim, PhD, on the Challenges Posed by the Solid Tumor Microenvironment
The cofounder and chief scientific officer of Xcell Biosciences discussed the limitations of the methods currently used for modeling in preclinical cell therapy research for solid tumors.